This page is not available in the language that has been selected and will appear in English.
This page is not available in the language that has been selected.
Halaman ini tidak tersedia dalam bahasa yang dipilih.
Trang này không có sẵn bằng ngôn ngữ đã chọn.
此页面不提供所选语言的版本。
1234 5678
John hits the road to celebrate the end of cancer treatment.
John hits the road to celebrate the end of cancer treatment
Sed aliquam tellus sit amet lectus suscipit molestie. Curabitur nec ultrices nunc, id feugiat nisi. Nam iaculis malesuada ex eget dictum.
Find a clinical trial that suits you and your cancer diagnosis
WOMBAT / ANZUP 2201
Evaluating the efficacy of bipolar androgen therapy in extending metastasis-free survival in patients with M0 castrate-resistant prostate cancer with prostate specific antigen progression but not radiological or clinical progression on darolutamide
Locations Chermside
Diagnosis Prostate cancer
MEVPRO-1 / C2321014
A Study to Learn About the Investigational Medicine Called PF-06821497 (Mevrometostat) in Men With mCRPC Who Were Previously Treated With Abiraterone Acetate for Prostate Cancer
Locations Wesley
NIAGARA-2 / D933RC00002
Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer
Diagnosis Bladder cancer
SKB264-II-06
SKB264 in Combination With Pembrolizumab in Subjects With Selected Solid Tumors
Diagnosis Advanced solid tumours
RAMP 301 / VS-6766-301
A Study of Avutometinib (VS-6766) + Defactinib (VS-6063) in Recurrent Low-Grade Serious Ovarian Cancer
Diagnosis Ovarian cancer
ZN-c3-005
A Study of Azenosertib (ZN-c3) in Subjects With Platinum-Resistant High-Grade Serous Ovarian, Fallopian Tube or Primary Peritoneal Cancer (DENALI)
Previous